RT @CochraneUK: Calcium channel blockers for people with chronic #kidneydisease requiring dialysis https://t.co/TOQPpZ2KE3 #CKD Systematic…
RT @CochraneUK: Calcium channel blockers for people with chronic #kidneydisease requiring dialysis https://t.co/TOQPpZ2KE3 #CKD Systematic…
RT @cochrane_nz: Calcium channel blockers for people with chronic #kidneydisease requiring dialysis https://t.co/CH7piY34qi #CKD Systematic…
Calcium channel blockers for people with chronic #kidneydisease requiring dialysis https://t.co/CH7piY34qi #CKD Systematic review from @CochraneKidney includes 13 studies randomising 1459 adults undergoing #haemodialysis. https://t.co/yxsvHa7nLL
RT @CochraneLibrary: Calcium channel blockers for people with chronic #kidneydisease requiring dialysis https://t.co/9sq20Kekyu #CKD System…
RT @CochraneLibrary: Calcium channel blockers for people with chronic #kidneydisease requiring dialysis https://t.co/9sq20Kekyu #CKD System…
RT @CochraneLibrary: Calcium channel blockers for people with chronic #kidneydisease requiring dialysis https://t.co/9sq20Kekyu #CKD System…
Calcium channel blockers for people with chronic #kidneydisease requiring dialysis https://t.co/9sq20Kekyu #CKD Systematic review from @CochraneKidney includes 13 studies randomising 1459 adults undergoing #haemodialysis.
RT @CochraneKidney: New Review: Calcium channel blockers for people with chronic kidney disease requiring dialysis. Discover the latest at…
RT @CochraneKidney: New Review: Calcium channel blockers for people with chronic kidney disease requiring dialysis. Discover the latest at…
Of interest for @drmiketodorovic regarding blood pressure management
RT @CochraneKidney: New Review: Calcium channel blockers for people with chronic kidney disease requiring dialysis. Discover the latest at…
RT @CochraneKidney: New Review: Calcium channel blockers for people with chronic kidney disease requiring dialysis. Discover the latest at…
New Review: Calcium channel blockers for people with chronic kidney disease requiring dialysis. Discover the latest at #CochraneEvidence https://t.co/x1VYnY2x6r #kidneydisease https://t.co/NBNAcfQRpt
RT @gstrip3: Dihydropyridine CCBs may decrease predialysis systolic and diastolic blood pressure level compared to placebo or no treatment.…
Dihydropyridine CCBs may decrease predialysis systolic and diastolic blood pressure level compared to placebo or no treatment. Evidence suboptimal. Read our work. https://t.co/BB1lZ2mvzr